pentoxifylline has been researched along with Candidiasis in 9 studies
Candidiasis: Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Since fungal septic shock with acute disseminated candidiasis evolves prior to significant increases in circulating TNF, PTX also appears ineffective in its treatment." | 5.29 | Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. ( Lechner, AJ; Matuschak, GM; Potthoff, LH; Rouben, LR; Tredway, TL, 1993) |
| " The toxic and antifungal effects of AmB with and without the vascular decongestants pentoxifylline (PTX) and a methylxanthine analog, HWA-138, were compared in the murine model of candidiasis." | 3.68 | Enhancement of the treatment of experimental candidiasis with vascular decongestants. ( Lopez-Berestein, G; Luke, DR; McQueen, TJ; Wasan, KM, 1990) |
| "Pentoxifylline has immunomodulatory properties and has been shown to decrease organ damage and improve survival in animals with gram-negative sepsis or endotoxemia." | 1.30 | Pharmacokinetics of pentoxifylline and its metabolites in healthy mice and in mice infected with Candida albicans. ( Baltch, AL; Davis, PJ; Gordon, MA; Louie, A; Miller, K; Smith, RP, 1998) |
| "Since fungal septic shock with acute disseminated candidiasis evolves prior to significant increases in circulating TNF, PTX also appears ineffective in its treatment." | 1.29 | Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. ( Lechner, AJ; Matuschak, GM; Potthoff, LH; Rouben, LR; Tredway, TL, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farkas, G | 1 |
| Márton, J | 1 |
| Mándi, Y | 1 |
| Leindler, L | 1 |
| Netea, MG | 1 |
| Blok, WL | 1 |
| Kullberg, BJ | 1 |
| Bemelmans, M | 1 |
| Vogels, MT | 1 |
| Buurman, WA | 1 |
| van der Meer, JW | 1 |
| Lechner, AJ | 1 |
| Rouben, LR | 1 |
| Potthoff, LH | 1 |
| Tredway, TL | 1 |
| Matuschak, GM | 1 |
| Louie, A | 2 |
| Baltch, AL | 2 |
| Franke, MA | 1 |
| Ritz, WJ | 1 |
| Smith, RP | 2 |
| Singh, JK | 1 |
| Gordon, MA | 2 |
| Miller, K | 1 |
| Davis, PJ | 1 |
| Wasan, KM | 3 |
| Vadiei, K | 2 |
| Luke, DR | 3 |
| Keyhani, A | 1 |
| White, RA | 1 |
| McQueen, TJ | 2 |
| Mehta, R | 1 |
| Lopez-Berestein, G | 3 |
| Verani, RR | 1 |
| Brunner, LJ | 1 |
| Berens, KL | 1 |
| Montgomery, B | 1 |
| Bianco, JA | 1 |
| Jacobsen, A | 1 |
| Singer, JW | 1 |
9 other studies available for pentoxifylline and Candidiasis
| Article | Year |
|---|---|
Surgical management and complex treatment of infected pancreatic necrosis: 18-year experience at a single center.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arginine; Candidiasis; Cause of Death; Cholecystectomy; Colec | 2006 |
Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice.
Topics: Animals; Candidiasis; Chlorpromazine; Female; Interleukin-1; Kidney; Klebsiella Infections; Klebsiel | 1995 |
Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock.
Topics: Animals; Bacteremia; Candidiasis; Escherichia coli Infections; Fungemia; Gene Expression; Male; Pent | 1993 |
Effect of pentoxifylline on the course of systemic Candida albicans infection in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Endotoxins; Humans; Interleukin-6; Kidney; Leukocyte Count; | 1996 |
Pharmacokinetics of pentoxifylline and its metabolites in healthy mice and in mice infected with Candida albicans.
Topics: Adjuvants, Immunologic; Animals; Candidiasis; Female; Mice; Pentoxifylline | 1998 |
Antifungal activity of HWA-138 and amphotericin B in experimental systemic candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Synergism; Mice; Mice, Inbred ICR; Pen | 1991 |
Attenuation of amphotericin-B nephrotoxicity in the candidiasis rat model.
Topics: Amphotericin B; Animals; Candidiasis; Dose-Response Relationship, Drug; Kidney; Male; Pentoxifylline | 1991 |
Localization of transfused neutrophils to site of infection during treatment with recombinant human granulocyte-macrophage colony-stimulating factor and pentoxifylline.
Topics: Abscess; Adult; Blood Transfusion; Bone Marrow Transplantation; Candidiasis; Granulocyte-Macrophage | 1991 |
Enhancement of the treatment of experimental candidiasis with vascular decongestants.
Topics: Amphotericin B; Animals; Candidiasis; Drug Therapy, Combination; Glomerular Filtration Rate; Kidney; | 1990 |